» Articles » PMID: 28103902

Relationship Between Crown-like Structures and Sex-steroid Hormones in Breast Adipose Tissue and Serum Among Postmenopausal Breast Cancer Patients

Abstract

Background: Postmenopausal obesity is associated with increased circulating levels of androgens and estrogens and elevated breast cancer risk. Crown-like structures (CLS; microscopic foci of dying adipocytes surrounded by macrophages) are proposed to represent sites of increased aromatization of androgens to estrogens. Accordingly, we examined relationships between CLS and sex-steroid hormones in breast adipose tissue and serum from postmenopausal breast cancer patients.

Methods: Formalin-fixed paraffin embedded benign breast tissues collected for research from postmenopausal women (n = 83) diagnosed with invasive breast cancer in the Polish Breast Cancer Study (PBCS) were evaluated. Tissues were immunohistochemically stained for CD68 to determine the presence of CLS per unit area of adipose tissue. Relationships were assessed between CD68 density and CLS and previously reported sex-steroid hormones quantified using radioimmunoassays in serum taken at the time of diagnosis and in fresh frozen adipose tissue taken at the time of surgery. Logistic regression analysis was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the relationships between hormones (in tertiles) and CLS.

Results: CLS were observed in 36% of benign breast tissues, with a higher frequency among obese versus lean women (54% versus 17%, p = 0.03). Detection of CLS was not related to individual hormone levels or breast tumor pathology characteristics. However, detection of CLS was associated with hormone ratios. Compared with women in the highest tertile of estrone:androstenedione ratio in fat, those in the lowest tertile were less likely to have CLS (OR 0.12, 95% CI 0.03-0.59). A similar pattern was observed with estradiol:testosterone ratio in serum and CLS (lowest versus highest tertile, OR 0.18, 95% CI 0.04-0.72).

Conclusions: CLS were more frequently identified in the breast fat of obese women and were associated with increased ratios of select estrogens:androgens in the blood and tissues, but not with individual hormones. Additional studies on CLS, tissue and blood hormone levels, and breast cancer risk are needed to understand and confirm these findings.

Citing Articles

Neighborhood Environment, DNA Methylation, and Presence of Crown-Like Structures of the Breast.

Harris A, Hughes J, Lawrence W, Lenz P, Franklin J, Bhawsar P JAMA Netw Open. 2025; 8(2):e2461334.

PMID: 39992653 PMC: 11851241. DOI: 10.1001/jamanetworkopen.2024.61334.


Histologic Characterization of Tumor-Adjacent Mammary Adipose Tissue in Normal-Weight and Overweight/Obese Patients with Triple-Negative Breast Cancer.

Wolf M, Brochhausen C, Ramakrishnan V, Iberl S, Roth J, Seitz S Cancers (Basel). 2024; 16(20).

PMID: 39456610 PMC: 11506523. DOI: 10.3390/cancers16203515.


Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy.

Yende A, Sharma D Front Immunol. 2024; 15:1444589.

PMID: 39253073 PMC: 11381382. DOI: 10.3389/fimmu.2024.1444589.


Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.

Wang J, Zhang W, Liu C, Wang L, Wu J, Sun C Int J Biol Sci. 2024; 20(5):1884-1904.

PMID: 38481820 PMC: 10929185. DOI: 10.7150/ijbs.92125.


Interaction between body mass index and family history of cancer on the risk of female breast cancer.

Cao J, Li J, Zhang Z, Qin G, Pang Y, Wu M Sci Rep. 2024; 14(1):4927.

PMID: 38418549 PMC: 10901816. DOI: 10.1038/s41598-024-54762-x.


References
1.
Ewertz M, Jensen M, Gunnarsdottir K, Hojris I, Jakobsen E, Nielsen D . Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2010; 29(1):25-31. DOI: 10.1200/JCO.2010.29.7614. View

2.
Bhardwaj P, Du B, Zhou X, Sue E, Giri D, Harbus M . Estrogen Protects against Obesity-Induced Mammary Gland Inflammation in Mice. Cancer Prev Res (Phila). 2015; 8(8):751-9. PMC: 4526346. DOI: 10.1158/1940-6207.CAPR-15-0082. View

3.
Martinez F, Gordon S . The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6:13. PMC: 3944738. DOI: 10.12703/P6-13. View

4.
Iyengar N, Zhou X, Gucalp A, Morris P, Howe L, Giri D . Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer. Clin Cancer Res. 2015; 22(9):2283-9. PMC: 4854755. DOI: 10.1158/1078-0432.CCR-15-2239. View

5.
Falk R, Gentzschein E, Stanczyk F, Brinton L, Garcia-Closas M, Ioffe O . Measurement of sex steroid hormones in breast adipocytes: methods and implications. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):1891-5. PMC: 2570742. DOI: 10.1158/1055-9965.EPI-08-0119. View